FDA
-
-
-
-
-
-
-
FDA grants Jaguar Health fee waivers for two drugs in fiscal 2027
-
-
-
-
-
-
-
Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF) Due to Microvillus Inclusion Disease (MVID)
-
-
-
-
-
-
-
Magdalena Biosciences coca extract prevents weight gain in mice
-
-
-
-
-
-
-
Jaguar Health Announces Active Treatment Only Continuation of Pivotal Multicenter Clinical Trial in Pediatric Patients with Microvillus Inclusion Disease (MVID) to Support a New Drug Application (NDA)
-
-
-
-
-
-
-
Artificial Intelligence (AI) Platforms Could Enhance Jaguar Health's Development and Anticipated Commercialization of Crofelemer for Rare Disease Intestinal Failure (IF) Programs
-
-
-
-
-
-
-
Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Initiates Preclinical Study of Coca for Appetite Suppression
-
-
-
-
-
-
-
Jaguar Health signs $38 million license deal with Future Pak
-
335,386 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


